User:Mr. Ibrahem/Aclidinium

Aclidinium is a medication used for maintenance treatment of chronic obstructive pulmonary disease (COPD). It may improve quality of life and prevent hospitalization; but does not affect the risk of death or the need for steroids. It is unclear if it differs from tiotropium or other medications in the LAMA class. It is used by a dry powder inhaler.

Common side effects include headache, cough, and inflammation of the nose and throat. Other side effects may include diarrhea, bronchospasm, and urinary retention. It is a long-acting muscarinic antagonist (LAMA).

Aclidinium was approved for medical use in the United States in 2012. It is on the World Health Organization's List of Essential Medicines as an alternative to tiotropium. In the United Kingdom a month costs the NHS about 33 pounds. In the United States this amount costs about 560 USD as of 2021. It is also available together with formoterol.